Navigation Links
Fetal Cell Transplant Found To Improve Movement In Patients With Parkinson’s Disease

Latest research shows that fetal cell transplantation for patients with Parkinson’s disease is helping some patients get rid of their medications altogether.//

Parkinson’s disease is a chronic neurological disease that impairs mobility. Patients with Parkinson’s lack the chemical dopamine, which is necessary for movement. Fetal cell transplantation involves transplanting aborted human fetal tissue to replace the lost dopamine-producing cells to help restore movement.

Levodopa (Dopar or Larodopa) is the gold standard treatment for Parkinson’s disease. While the drug offers substantial relief, research shows it tends to lose its effectiveness after five to 10 years of use. Researchers say after one year, the transplant is equivalent to about 30-percent of the levodopa people take. After two years, it’s equivalent to about 50 percent. By the third year, the procedure’s effect is about 60 percent, or two-thirds, the effect of the drug and they say, that it is enough for some people to stop taking their drgs.
'"/>




Page: 1

Related medicine news :

1. Fish Found To Improve Fetal Growth
2. Vitamin Supplements During Pregnancy to Boost Fetal Development
3. Worried About The Sensitive Skin Of Your 2 Year Old? Fetal Skin Cells To Offer Help
4. Using Eyes As The Line Of Reference For Fetal Brain Imaging
5. Simple Eye Movement Test For Early Detection Of Fetal Alcohol Spectrum Disorder
6. Genetic Disorders, Not Fetal Distress Increase Cerebral Palsy Risk
7. Fetal Development Face The Threat By Frequent Ultrasounds
8. New Drug Could Prevent Fetal Alcohol Syndrome
9. Fetal Neural Grafts Improves Motor and Cognitive Function in Huntington Patients
10. Epilepsy Drug Poses High Risk for Fetal Death and Birth Defects
11. Americans Deficient In Dietary Intake Of Choline Needed for Fetal Brain Development

Post Your Comments:
(Date:11/24/2009)...November24/PRNewswire-FirstCall/--ICL(TASE:ICL),a,...y,todayreported,resultsforthethirdquarterandninemo...fortheThirdQuarter , Revenues:Revenuesforthet...dsequentiallywith$1,083millionforthesecondquartero...illion,reflecting,theexceptionaldemandandpricestha...
(Date:11/24/2009)... Slate and New Markets build on their combined st...r. , Baltimore, Md. (PRWE...slatecap.com ), a private equity firm based in Bal... ( www.newmarketsvp.com ), a venture capital firm ...hat they have acquired Ecoast Sales Solutions, Ltd...
(Date:11/24/2009)... The GeoPense World Volunteer Computing Team has ...the Quantum Monte Carlo method to problems in Quan...s important in life science research. This project...Einstein@home (gravity wave detection), and GPUGr... , (PRWEB) November 24, 2...
(Date:11/24/2009)... NCL Security Launches EyeCentral Remote Video Pl...ring Monthly Revenue for Central Stations and Secu...exas (PRWEB) November 24, 2009 -- NCL Security Lau...urity Industry to Generate Recurring Monthly Reven..."Integrated security systems has been and sti...
(Date:11/23/2009)...ember 18, 2009 -- A team of researchers at the Uni...ersity has developed a way to simulate blood flow ...s the basis of a new tool that may help surgeons p..." surgery, which is performed on babies born with ...ers will present their work next week at the 62nd ...
Breaking Medicine News(10 mins):Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 2Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 3Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 4Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 5Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 6Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 7Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 2Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 3Health News:GeoPense Announces it has Joined QMC@home Project 2Health News:NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Dealers 2Health News:New tool for helping pediatric heart surgery 2
...f the feared form of epidemic fevers, is spread by.... "We have 12 deaths (in the past fortnight) fr...firmed cases in city hospitals, " Maharashtra stat...octors and the patients come to public hospitals w...
...g cessation drug Zyban, which is being taken by ov...le for a raise in the suspected adverse reactions ...atistics of MCA has shown a raise of about 37% mor... the main factor responsible for such an increase ...
...e most common neurological disorder and one of the...illion people die of stroke each year and more tha...question of the day is about the recovery - whethe...ryland devised a method which allows doctors to gi...
...ging of shirts - the result of excessive sweating ...arrasment. Botox, a purified form of Botulinum tox...g hyperhydrosis. Prescription antiperspirants a...otulinum toxin into the skin does a greater relief...
...ve gentlemen with a rare genetic mutation that co... David G. Huntsman of the British Columbia Cancer...t on five members of two families with a rare form... cancer. On this basis these members were taken...
...on's 41st Annual Conference on Cardiovascular Dise...xas, has unveiled a new cousin counterpart to hear...s the risk of heart disease. Carlos Iribarren, ...an nonsmoking patients without asthma. Therefore e...
Other Medicine News:Health News:Asthma! A new warning for heart disease 2
(Date:11/23/2009)...INTRICHMOND,Calif.,Nov.23/PRNewswire-FirstCall/--T...nouncedthatitisscheduledtomeetwiththeU.S.FoodandDr...ompleteResponseLetterregardingtheNewDrugApplicatio...ingualtablet).Aspreviouslyannounced,theCompleteRes...dicatedthattheFDAcouldnotapprovetheNDAinitspresent...
(Date:11/23/2009)...MBRIDGE,Mass.,Nov.23/PRNewswire/--LigonDiscovery,I...hnologytofinddrugsagainsthigh-valuetargets,todayan...anErrolB.DeSouzaasLigon,sExecutiveChairmanoftheBoa...ecutiveChairmanoftheBoard,"saidPatrickKleyn,Ligon,...,sbreadthofexperienceinthelifesciencesindustry--pa...
(Date:11/23/2009)...llowingtheFDAapprovalsoftwonewtherapiesforNon-Hodg...nupdatedtoincludeofatumumab(Azerra(TM),GlaxoSmithK...yticleukemia(CLL)andromidepsin(Istodax(R),Gloucest...withcutaneousT-celllymphoma(CTCL). ,, FORTWASHI...FDAapprovalshavepromptedtheNationalComprehensiveCa...
Breaking Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3CEL SCI Corporation to Raise 2420 Million in Registered Direct Offering 57405 1CEL SCI Corporation to Raise 2420 Million in Registered Direct Offering 57405 2CEL SCI Corporation to Raise 2420 Million in Registered Direct Offering 57405 3Prescient Medical vProtect 28TM 29 Luminal Shield Receives North American Product Innovation of the Year Award from Frost 26 Sullivan 57403 1Prescient Medical vProtect 28TM 29 Luminal Shield Receives North American Product Innovation of the Year Award from Frost 26 Sullivan 57403 2PharmAbcine Closes USD 246 Million Series A Financing 14102 1PharmAbcine Closes USD 246 Million Series A Financing 14102 2PharmAbcine Closes USD 246 Million Series A Financing 14102 3PharmAbcine Closes USD 246 Million Series A Financing 14102 4
Hip Abduction Orthosis
Hip Stabilizers
HighTide Diabetic
Cam Walker® II
Medicine Products: